Mydriacyl (Tropicamide)

Tropicamide, the active ingredient in Mydriacyl, is an antimuscarinic (muscarinic antagonist) presented as an ophthalmic solution for ocular (topical) use. It produces rapid pupil dilation and temporary paralysis of the ciliary muscle, facilitating comprehensive eye examinations and certain diagnostic procedures.

GNH USA supplies Mydriacyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory conformity for ophthalmic care. The product complies with European Union pharmacopeial standards and is distributed under appropriate import licences.

Tropicamide, a muscarinic antagonist used in ophthalmology, is employed to achieve controlled pupil dilation and cycloplegia. - Diagnostic eye examinations: provides mydriasis to allow thorough retinal and optic nerve assessment. - Fundus photography: enables clear imaging of the posterior segment. - Laser procedures: facilitates access for retinal laser therapy.

Tropicamide may cause several ocular reactions after administration.

Common Side Effects: - Blurred vision: temporary loss of near focus after instillation. - Photophobia: increased sensitivity to light due to dilated pupil. - Stinging or burning sensation: mild ocular discomfort on application. - Transient rise in intraocular pressure: short‑term elevation that usually resolves.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma: sudden painful eye pressure increase requiring urgent care. - Severe allergic reaction: swelling, redness, or rash around the eye. - Corneal edema: swelling of the cornea that may affect vision. - Persistent mydriasis: prolonged pupil dilation lasting beyond the expected period.

Prior to using Mydriacyl, certain safety measures should be observed. - Assess angle status: evaluate for narrow‑angle glaucoma before use. - Avoid in hypersensitivity: do not use if the patient is allergic to tropicamide or other antimuscarinics. - Use minimal effective dose: limit the number of drops to the prescribed amount. - Monitor intraocular pressure: especially in patients at risk for glaucoma. - Inform patients about temporary visual disturbances and advise protective eyewear. - Store at room temperature: keep in original container, protect from light and moisture.

Tropicamide can interact with other ophthalmic and systemic agents.

Major Interactions (Avoid): - Other mydriatics (e.g., phenylephrine): additive mydriasis, risk of excessive dilation. - Systemic anticholinergics (e.g., atropine): increased anticholinergic load. - Topical ocular NSAIDs: may increase risk of corneal irritation.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: monitor intraocular pressure changes. - Systemic cholinesterase inhibitors (e.g., donepezil): may reduce efficacy of tropicamide.